Shots:

• The two studies include investigator-led study & Global SYMPLICITY Registry results involves the assessing of Symplicity renal denervation system vs sham in 80 & 2-600 patients with uncontrolled hypertension
• Collective results: atrial fibrillation (AF) occurrence (19% vs 47%); reductions in both office and ambulatory blood pressure (16.5 mm Hg OSBP and 8.9 mm Hg 24H systolic ABPM)- sustained reduction in BP in diabetes- ISH- CKD; safe & effective- presented at EuroPCR- 2019
• Medtronic’s Symplicity is also evaluated 70-patient SYMPLICITY AF study assessing renal denervation system in patients with paroxysmal and persistent atrial fibrillation and is approved in 50+ countries

Ref: Medtronic | Image: Twitter